ArticleBritish journal of pharmacology2014

Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetes.

D J Baker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.